- Trials with a EudraCT protocol (553)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
553 result(s) found for: No Smoking Day.
Displaying page 6 of 28.
EudraCT Number: 2012-004966-16 | Sponsor Protocol Number: CQVA149A2318 | Start Date*: 2013-02-27 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A 52-week treatment, multi-center, randomized, double-blind, double-dummy, parallel-group, active controlled study to compare the effect of QVA149 (indacaterol maleate / glycopyrronium bromide) wit... | |||||||||||||
Medical condition: subjects with moderate to very severe COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) HU (Completed) SE (Completed) ES (Completed) AT (Completed) LT (Completed) NL (Completed) CZ (Completed) FI (Completed) DE (Completed) BE (Completed) IS (Completed) IT (Completed) PT (Completed) NO (Completed) PL (Completed) EE (Completed) DK (Completed) BG (Completed) LV (Completed) GR (Completed) GB (Completed) LU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023444-32 | Sponsor Protocol Number: DB2114418 | Start Date*: 2011-04-27 | |||||||||||
Sponsor Name:GlaxoSmithKline | |||||||||||||
Full Title: An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444. | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) GB (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002156-16 | Sponsor Protocol Number: DB2114951 | Start Date*: 2014-08-13 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A randomized, multi-center, double-blind, doubledummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000495-28 | Sponsor Protocol Number: 132 | Start Date*: 2017-05-18 | |||||||||||||||||||||
Sponsor Name:Respiratory Research Unit, Bispebjerg University Hospital | |||||||||||||||||||||||
Full Title: SIGNATURE - the 6-gene signature as a predictor of response to treatment in severe asthma and ACOS | |||||||||||||||||||||||
Medical condition: Severe asthma and astma-COPD overlap syndrome | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-015901-38 | Sponsor Protocol Number: M/40464/26 | Start Date*: 2010-02-02 | |||||||||||
Sponsor Name:ALMIRALL, S.A. | |||||||||||||
Full Title: Efficacy, safety and tolerability of two Fixed-Dose Combinations of Aclidinium bromide with two doses of Formoterol fumarate compared with Aclidinium bromide, Formoterol fumarate and placebo all ad... | |||||||||||||
Medical condition: Moderate to severe chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) CZ (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000525-45 | Sponsor Protocol Number: DB2114930 | Start Date*: 2013-01-10 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: DB2114930: A randomized, multi-center, double-blind, doubledummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmetero... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003675-21 | Sponsor Protocol Number: 205724 | Start Date*: 2017-06-01 | |||||||||||
Sponsor Name:GlaxoSmithKline, S.A. | |||||||||||||
Full Title: Randomised, Double-Blind (Sponsor Open), Placebo-Controlled, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of Danirixin Tablets Administered Twice Daily Compared With Placebo ... | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) NL (Completed) PL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000010-36 | Sponsor Protocol Number: M/34273/25 | Start Date*: 2007-10-18 | |||||||||||
Sponsor Name:Laboratorios Almirall, S.A. | |||||||||||||
Full Title: A multiple dose, double-blind, double-dummy, 3 period cross-over, placebo controlled clinical trial to assess the efficacy and safety of once daily inhaled aclidinium bromide 200 µg given either in... | |||||||||||||
Medical condition: Stable moderate to severe Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000529-19 | Sponsor Protocol Number: 201211 | Start Date*: 2014-05-22 | |||||||||||
Sponsor Name:GlaxoSmithKline R&D | |||||||||||||
Full Title: A 12 week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy of Umeclidinium/Vilanterol 62.5/25mcg in Subjects with COPD | |||||||||||||
Medical condition: Subjects with COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) RO (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000619-58 | Sponsor Protocol Number: 19CH214 | Start Date*: 2021-02-01 | |||||||||||
Sponsor Name:CHU SAINT-ETIENNE | |||||||||||||
Full Title: A pilot study assessing the feasibility of a randomized controlled trial evaluating aspirin in postpartum women at risk of developing venous thromboembolism Pilot PARTUM Trial: Postpartum Aspirin... | |||||||||||||
Medical condition: Post-Partum Venous thromboembolism prophylaxis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003780-38 | Sponsor Protocol Number: P05575 | Start Date*: 2009-10-27 | |||||||||||
Sponsor Name:Schering-Plough Research Institute | |||||||||||||
Full Title: A 2-Year, Dose Range-Finding, Adaptive-Design Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPD | |||||||||||||
Medical condition: COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) CZ (Prematurely Ended) SK (Completed) GR (Prematurely Ended) IT (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023349-32 | Sponsor Protocol Number: DB2113373 | Start Date*: 2011-05-26 | |||||||||||
Sponsor Name:GlaxoSmithKline, S.A. | |||||||||||||
Full Title: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 Inhalation Powder and the Individual Components Delivered Once-Daily via a N... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) GR (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000834-12 | Sponsor Protocol Number: M/34273/39 | Start Date*: 2011-10-04 | |||||||||||
Sponsor Name:Almirall S.A. | |||||||||||||
Full Title: A MULTIPLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED, PARALLEL CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY INHALED ACLIDINIUM BROMIDE 400 μg COMPARED TO PLACEBO AND T... | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) CZ (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004466-41 | Sponsor Protocol Number: A6631011 | Start Date*: 2008-02-26 | |||||||||||
Sponsor Name:Pfizer Ltd, Ramsgate Road, Sandwich, Kent | |||||||||||||
Full Title: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ORALLY ADMINISTERED PH-797804 (0.5, 3, 6 AND 10 MG) IN ADULTS WITH M... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) FR (Completed) GR (Completed) NL (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003073-10 | Sponsor Protocol Number: CTT116853 | Start Date*: 2014-09-16 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development | |||||||||||||
Full Title: A Phase III, 24 week, randomized, double blind, double dummy, parallel group study (with an extension to 52 weeks in a subset of subjects) comparing the efficacy, safety and tolerability of the fix... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) SK (Completed) GR (Completed) DE (Completed) CZ (Completed) PL (Completed) BG (Completed) EE (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003588-31 | Sponsor Protocol Number: CCD-1106-PR-0066 | Start Date*: 2012-02-03 | |||||||||||
Sponsor Name:Chiesi Farmaceutici S.p.A. | |||||||||||||
Full Title: A multicentre, randomised, double-blind, active-controlled, 4-way cross-over study to evaluate the efficacy and safety of a free combination of 3 doses of Glycopyrrolate with fixed combination Becl... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) HU (Completed) IT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014551-80 | Sponsor Protocol Number: 1268.16 | Start Date*: 2010-01-21 | |||||||||||
Sponsor Name:BOEHRINGER ING. | |||||||||||||
Full Title: Randomised, double-blind, double-dummy, placebo-controlled, parallel group study to assess the efficacy and safety of 6 weeks of oral BI 671800 ED 400 mg b.i.d., Montelukast 10 mg q.d., or placeb... | |||||||||||||
Medical condition: patients with symptomatic asthma on inhaled corticosteroids | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) SE (Completed) DE (Completed) GB (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002665-38 | Sponsor Protocol Number: M/34273/40 | Start Date*: 2011-10-05 | |||||||||||
Sponsor Name:Almirall S.A. | |||||||||||||
Full Title: A MULTIPLE DOSE, RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, 2 PERIOD CROSSOVER CLINICAL TRIAL TO ASSESS THE EFFECT OF ACLIDINIUM BROMIDE 400 μg BID ON EXERCISE ENDURANCE IN PATIENTS WITH STABLE ... | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005804-17 | Sponsor Protocol Number: M/34273/24 | Start Date*: 2007-02-08 | |||||||||||
Sponsor Name:Laboratorios Almirall, S.A. | |||||||||||||
Full Title: A Single Dose, Double-Blind, Double-Dummy, 3 Period Cross-Over, Placebo Controlled Clinical Trial To Assess the Rate of Onset of Action of Inhaled LAS 34273 200µg Compared To Placebo and Tiotropium... | |||||||||||||
Medical condition: Phase III placebo controlled crossover trial to better characterise the acute effect of LAS 34273 on bronchodilation action in severe COPD patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002667-15 | Sponsor Protocol Number: 05201401 | Start Date*: 2014-09-23 |
Sponsor Name:Medizinische Universität Innsbruck, Innere Medizin VI | ||
Full Title: Effect of Dual Bronchodilatation on Broncholysis Testing in COPD Patients | ||
Medical condition: COPD (chronic obstructive pulmonary disease) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
